journal article·2018-11-01Open access

Effects of Deuteration of 13C-Enriched Phospholactate on Efficiency of Parahydrogen-Induced Polarization by Magnetic Field Cycling

Oleg G. Salnikov, Roman V. Shchepin, Nikita V. Chukanov, Lamya Jaigirdar, Wellington Pham, Kirill V. Kovtunov, Igor V. Koptyug, Eduard Y. Chekmenev

The Journal of Physical Chemistry C· Volume 122· Issue 43

Abstract

We report herein a large-scale (>10 g) synthesis of isotopically enriched 1- 13 C-phosphoenolpyruvate and 1- 13 C-phosphoenolpyruvate- d 2 for application in hyperpolarized imaging technology. 1- 13 C-Phosphoenolpyruvate- d 2 was synthesized with 57% overall yield (over two steps), and >98% 2 H isotopic purity, representing an improvement over the previous report. The same outcome was achieved for 1- 13 C-phosphoenolpyruvate. These two unsaturated compounds with C═C bonds were employed for parahydrogen-induced polarization via pairwise parahydrogen addition in aqueous medium. We find that deuteration of 1- 13 C-phosphoenolpyruvate resulted in overall increase of 1 H T 1 of nascent hyperpolarized protons (4.30 ± 0.04 s versus 2.06 ± 0.01 s) and 1 H polarization (∼2.5% versus ∼0.7%) of the resulting hyperpolarized 1- 13 C-phospholactate. The nuclear spin polarization of nascent parahydrogen-derived protons was transferred to 1- 13 C nucleus via a magnetic field cycling procedure. The proton T 1 increase in deuterated hyperpolarized 1- 13 C-phospholactate yielded approximately 30% better 13 C polarization compared to that of nondeuterated hyperpolarized 1- 13 C-phospholactate. Analysis of T 1 relaxation revealed that deuteration of 1- 13 C-phospholactate may have resulted in approximately 3-fold worse 1 H → 13 C polarization transfer efficiency via magnetic field cycling. Since magnetic field cycling is a key polarization transfer step in the side-arm hydrogenation approach, the presented findings may guide more rational design of a broad range of 13 C hyperpolarized contrast agents for molecular imaging employing 13 C MRI. The hyperpolarized 1- 13 C-phospholactate- d 2 is of biomedical imaging relevance because it undergoes in vivo dephosphorylation and becomes 13 C hyperpolarized lactate, which as we show can be detected in the brain by 13 C hyperpolarized MRI; this feasibility demonstration has implications for future imaging of neurodegenerative diseases and dementia.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced NMR Techniques and Applications · Solid-state spectroscopy and crystallography · Atomic and Subatomic Physics Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

International Tomography Center SB RAS, 3A Institutskaya Street, Novosibirsk 630090, Russia

Novosibirsk State University, 2 Pirogova Street, Novosibirsk 630090, Russia

Department of Chemistry, Integrative Biosciences (Ibio), Karmanos Cancer Institute (KCI), Wayne State University, Detroit, Michigan 48202, United States

Russian Academy of Sciences, Leninskiy Prospekt 14, Moscow 119991, Russia

Funding

Division of Chemistry · National Cancer Institute · National Institute of Biomedical Imaging and Bioengineering · Russian Foundation for Basic Research · Congressionally Directed Medical Research Programs · Federal Agency for Scientific Organizations

References (81)

Show source-provided references
1. 10.1021/ja00260a02610.1021/ja00260a026 ↗
2. 10.1016/S0079-6565(97)00007-110.1016/S0079-6565(97)00007-1 ↗
3. 10.1002/chem.20160388410.1002/chem.201603884 ↗
4. 10.1002/anie.20171184210.1002/anie.201711842 ↗
5. 10.1002/asia.20180055110.1002/asia.201800551 ↗
6. 10.1002/9780470034590.emrstm145710.1002/9780470034590.emrstm1457 ↗
7. 10.1016/j.pnmrs.2012.03.00110.1016/j.pnmrs.2012.03.001 ↗
8. 10.1007/128_2012_37110.1007/128_2012_371 ↗
9. 10.1103/PhysRevLett.57.264510.1103/PhysRevLett.57.2645 ↗
10. 10.1021/ja00252a04910.1021/ja00252a049 ↗
11. 10.1002/anie.20170131410.1002/anie.201701314 ↗
12. 10.1002/cphc.20160056410.1002/cphc.201600564 ↗
13. 10.1016/j.crhy.2005.03.00210.1016/j.crhy.2005.03.002 ↗
14. 10.1016/j.crci.2005.05.01010.1016/j.crci.2005.05.010 ↗
15. 10.1002/mrm.115210.1002/mrm.1152 ↗
16. 10.1021/acs.jpcc.6b0755510.1021/acs.jpcc.6b07555 ↗
17. 10.1007/s10334-005-0007-x10.1007/s10334-005-0007-x ↗
18. 10.1021/acs.jpcc.7b0591210.1021/acs.jpcc.7b05912 ↗
19. 10.1002/nbm.175710.1002/nbm.1757 ↗
20. 10.1016/j.crhy.2004.02.00110.1016/j.crhy.2004.02.001 ↗
21. 10.1002/mrm.2084710.1002/mrm.20847 ↗
22. 10.1016/j.jmr.2007.01.01710.1016/j.jmr.2007.01.017 ↗
23. 10.1021/ja710121810.1021/ja7101218 ↗
24. 10.1007/s10334-008-0155-x10.1007/s10334-008-0155-x ↗
25. 10.1002/nbm.171710.1002/nbm.1717 ↗
26. 10.1021/ja204086510.1021/ja2040865 ↗
27. 10.4172/2155-9937.100012310.4172/2155-9937.1000123 ↗
28. 10.1021/acs.analchem.6b0213010.1021/acs.analchem.6b02130 ↗
29. 10.1016/j.jmr.2017.06.00910.1016/j.jmr.2017.06.009 ↗
30. 10.1016/j.mri.2004.11.03110.1016/j.mri.2004.11.031 ↗
31. 10.1016/j.jmr.2010.03.00410.1016/j.jmr.2010.03.004 ↗
32. 10.1021/jp308946210.1021/jp3089462 ↗
33. 10.1021/ja960067f10.1021/ja960067f ↗
34. 10.1007/s10334-008-0154-y10.1007/s10334-008-0154-y ↗
35. 10.1016/j.jmr.2012.08.01610.1016/j.jmr.2012.08.016 ↗
36. 10.1021/ja108529m10.1021/ja108529m ↗
37. 10.1016/j.jmr.2012.04.01210.1016/j.jmr.2012.04.012 ↗
38. 10.1016/j.jmr.2016.10.00910.1016/j.jmr.2016.10.009 ↗
39. 10.1021/jz501754j10.1021/jz501754j ↗
40. 10.1021/ja805973310.1021/ja8059733 ↗
41. 10.1002/anie.20160052110.1002/anie.201600521 ↗
42. 10.1038/ncomms685810.1038/ncomms6858 ↗
43. 10.1016/j.jmr.2017.09.01310.1016/j.jmr.2017.09.013 ↗
44. 10.1063/1.487079710.1063/1.4870797 ↗
45. 10.1021/ja101399q10.1021/ja101399q ↗
46. 10.1021/ja209884h10.1021/ja209884h ↗
47. 10.1021/acs.jpcb.5b0622210.1021/acs.jpcb.5b06222 ↗
48. 10.1002/chem.20160532910.1002/chem.201605329 ↗
49. 10.1021/acsomega.8b0098310.1021/acsomega.8b00983 ↗
50. 10.1016/j.jmr.2018.01.01910.1016/j.jmr.2018.01.019 ↗
51. 10.1073/pnas.060131910310.1073/pnas.0601319103 ↗
52. 10.1158/0008-5472.CAN-08-074910.1158/0008-5472.CAN-08-0749 ↗
53. 10.1038/nm165010.1038/nm1650 ↗
54. 10.1002/mrm.2198710.1002/mrm.21987 ↗
55. 10.1021/bi501225t10.1021/bi501225t ↗
56. 10.1073/pnas.070623510410.1073/pnas.0706235104 ↗
57. 10.1002/mrm.2236410.1002/mrm.22364 ↗
58. 10.1126/scitranslmed.300607010.1126/scitranslmed.3006070 ↗
59. 10.1016/j.ab.2017.01.01910.1016/j.ab.2017.01.019 ↗
60. 10.1002/nbm.84410.1002/nbm.844 ↗
61. 10.1038/nm.341510.1038/nm.3415 ↗
62. 10.1016/j.cmet.2016.06.00510.1016/j.cmet.2016.06.005 ↗
63. 10.1038/jcbfm.2012.13610.1038/jcbfm.2012.136 ↗
64. 10.1074/jbc.M109.06640710.1074/jbc.M109.066407 ↗
65. 10.1038/s41598-018-26583-210.1038/s41598-018-26583-2 ↗
66. 10.1039/C6CP00589F10.1039/C6CP00589F ↗
67. 10.1002/open.20180008610.1002/open.201800086 ↗
68. 10.1002/jlcr.320710.1002/jlcr.3207 ↗
69. 10.1021/ac500952z10.1021/ac500952z ↗
70. 10.1016/0009-2614(88)80002-210.1016/0009-2614(88)80002-2 ↗
71. 10.1021/jo00140a03610.1021/jo00140a036 ↗
72. 10.1021/acs.jpcc.8b0028310.1021/acs.jpcc.8b00283 ↗
73. 10.1016/j.jmr.2011.11.00110.1016/j.jmr.2011.11.001 ↗
74. 10.1002/mrc.470310.1002/mrc.4703 ↗
75. 10.1039/C8CC02246A10.1039/C8CC02246A ↗
76. 10.1063/1.161552210.1063/1.1615522 ↗
77. 10.1021/jz301389r10.1021/jz301389r ↗
78. 10.1038/ncomms1453510.1038/ncomms14535 ↗
79. 10.3233/JAD-16028910.3233/JAD-160289 ↗
80. 10.1002/mrm.2265010.1002/mrm.22650 ↗
81. 10.1016/j.mri.2012.06.03710.1016/j.mri.2012.06.037 ↗